Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
Désirée van der Heijde, Atul Deodhar, Walter P Maksymowych, Joachim Sieper, Filip Van den Bosch, Tae-Hwan Kim, Mitsumasa Kishimoto, Andrew J Östör, Bernard Combe, Yunxia Sui, Yuanyuan Duan, Peter K Wung, In-Ho Song
RMD Open Jul 2022, 8 (2) e002280; DOI: 10.1136/rmdopen-2022-002280